FDA-cleared device kills airborne microbes in hospitals
With US$3 million in new funding on the horizon, Biomoneta wants to bring its hospital-grade infection prevention technology to global markets.
We haven't written up this one. Tech in Asia has the full story — the link below goes straight to it.